Jagadananda Ghosh

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Prostate Cancer

Induced Apoptosis

Hepatitis C Virus

Top Venues

Molecular cancer therapeutics

Scientific reports

Jadavpur University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Jadavpur University

India

PHD

Publications

Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells. Molecular cancer therapeutics 22 (3) (2023)
Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an antiviral drug, downregulates Tribbles 2 pseudokinase and re-sensitizes enzalutamide resistant prostate cancer cells. Molecular cancer therapeutics (2023)
Jitender Monga, Frederick Valeriote, Clara Hwang, Shirish M Gadgeel, Jagadananda Ghosh
Daclatasvir, an Antiviral Drug, Downregulates Tribbles 2 Pseudokinase and Resensitizes Enzalutamide-Resistant Prostate Cancer Cells. Molecular cancer therapeutics 22 (3) (2023)
Jitender Monga, Dhatchayini Subramani, Ajay Bharathan, Jagadananda Ghosh
Pharmacological and genetic targeting of 5-lipoxygenase interrupts c-Myc oncogenic signaling and kills enzalutamide-resistant prostate cancer cells via apoptosis. Scientific reports 10 (1) (2020)